Comparing Anti-Inflammatory Effects of Serratiopeptidase and Diclofenac in Rats
Author Information
Author(s): Shilpa P. Jadav, Nilesh H. Patel, Tarang G. Shah, Maganlal V. Gajera, Hiren R. Trivedi, Bharat K. Shah
Primary Institution: M.P. Shah Medical College, Jamnagar, Gujarat, India
Hypothesis
The study aims to compare the anti-inflammatory effects of serratiopeptidase and diclofenac sodium in albino rats.
Conclusion
Serratiopeptidase is effective in reducing inflammation and is comparable to diclofenac sodium in both acute and chronic phases.
Supporting Evidence
- Serratiopeptidase significantly inhibited acute inflammation of paw at multiple time points after formalin injection.
- Percent inhibition of inflammation was comparable between serratiopeptidase and diclofenac.
- Serratiopeptidase showed significant inhibition of chronic inflammation up to the tenth day.
Takeaway
This study tested a medicine called serratiopeptidase to see if it helps reduce swelling in rats, and it found that it works almost as well as another medicine called diclofenac.
Methodology
The study involved 16 albino rats divided into four groups, with inflammation induced by formalin and treated with either serratiopeptidase or diclofenac.
Limitations
Single model study, relatively small sample size, and possible subjective error in assessing paw edema.
Participant Demographics
Charles foster albino rats of either sex weighing 150-250 g.
Statistical Information
P-Value
p = 0.018
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website